DE60316297D1 - Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antworten - Google Patents
Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antwortenInfo
- Publication number
- DE60316297D1 DE60316297D1 DE60316297T DE60316297T DE60316297D1 DE 60316297 D1 DE60316297 D1 DE 60316297D1 DE 60316297 T DE60316297 T DE 60316297T DE 60316297 T DE60316297 T DE 60316297T DE 60316297 D1 DE60316297 D1 DE 60316297D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- therapy
- diseases
- angiogener
- compounds useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 2
- 208000002780 macular degeneration Diseases 0.000 abstract 2
- 206010012646 Diabetic blindness Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000002001 anti-metastasis Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200201165 | 2002-08-01 | ||
| DKPA200201165 | 2002-08-01 | ||
| DKPA200201839 | 2002-11-28 | ||
| DK200201839 | 2002-11-28 | ||
| DK200300371 | 2003-03-11 | ||
| DKPA200300371 | 2003-03-11 | ||
| PCT/DK2003/000518 WO2004012733A2 (en) | 2002-08-01 | 2003-07-31 | Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60316297D1 true DE60316297D1 (de) | 2007-10-25 |
| DE60316297T2 DE60316297T2 (de) | 2008-06-19 |
Family
ID=31498946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60316297T Expired - Lifetime DE60316297T2 (de) | 2002-08-01 | 2003-07-31 | Verbindungen, die zur behandlung von erkrankungen, die auf antiangiogene therapie ansprechen, nützlich sind |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20060058395A1 (de) |
| EP (1) | EP1526851B1 (de) |
| JP (1) | JP2005537336A (de) |
| KR (1) | KR20050026091A (de) |
| CN (1) | CN1671378A (de) |
| AT (1) | ATE372770T1 (de) |
| AU (1) | AU2003260280A1 (de) |
| BR (1) | BR0312929A (de) |
| CA (1) | CA2493253A1 (de) |
| DE (1) | DE60316297T2 (de) |
| IL (1) | IL166040A0 (de) |
| IS (1) | IS7723A (de) |
| MX (1) | MXPA05001235A (de) |
| NO (1) | NO20051074L (de) |
| NZ (1) | NZ537809A (de) |
| PL (1) | PL375318A1 (de) |
| WO (1) | WO2004012733A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006527735A (ja) * | 2003-06-17 | 2006-12-07 | ノイロサーチ アクティーゼルスカブ | ジフェニル尿素誘導体、及びクロライドチャネル遮断剤としてのそれらの使用 |
| US7550499B2 (en) | 2004-05-12 | 2009-06-23 | Bristol-Myers Squibb Company | Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| JP2008527043A (ja) | 2005-01-19 | 2008-07-24 | ブリストル−マイヤーズ スクイブ カンパニー | 血栓塞栓障害治療用のｐ２ｙ１受容体阻害剤としての２−フェノキシ−ｎ−（１，３，４−チアジアゾール−２−イル）ピリジン−３−アミン誘導体および関連化合物 |
| US20100129477A1 (en) * | 2005-02-08 | 2010-05-27 | Zvi Ben Moshe | Composition for treatment of skin disorders |
| WO2007002584A1 (en) | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| US7728008B2 (en) | 2005-06-27 | 2010-06-01 | Bristol-Myers Squibb Company | N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| US7714002B2 (en) | 2005-06-27 | 2010-05-11 | Bristol-Myers Squibb Company | Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| WO2007002635A2 (en) | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| US7960569B2 (en) | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| WO2009054878A2 (en) * | 2007-09-11 | 2009-04-30 | University Of Florida Research Foundation | Compositions and methods for the treatment of neoplasia |
| WO2016001452A1 (en) * | 2014-07-04 | 2016-01-07 | Universität Zürich | Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated |
| JP7033554B2 (ja) | 2016-05-17 | 2022-03-10 | スカンジオン オンコロジー エー／エス | がんの併用療法 |
| WO2020049139A1 (en) * | 2018-09-06 | 2020-03-12 | Scandion Oncology A/S | Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11503110A (ja) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体拮抗剤 |
| JP2001521532A (ja) * | 1997-04-22 | 2001-11-06 | ニューロサーアチ・アクティーゼルスカブ | 置換されたフエニル誘導体、その製造方法及びその使用方法 |
| NZ505843A (en) * | 1997-12-22 | 2003-06-30 | Bayer Ag | Diphenyl ureas compounds for treating cancer and raf kinase related diseases |
| AU759275B2 (en) * | 1998-10-22 | 2003-04-10 | Neurosearch A/S | Substituted phenyl derivatives, their preparation and use |
| CO5200760A1 (es) * | 1999-06-16 | 2002-09-27 | Smithkline Beecham Corp | Antagonistas del receptor de la il-8 ceptor il-8 |
| NZ537251A (en) * | 2002-07-09 | 2007-02-23 | Bristol Myers Squibb Co | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
-
2003
- 2003-07-31 US US10/522,258 patent/US20060058395A1/en not_active Abandoned
- 2003-07-31 WO PCT/DK2003/000518 patent/WO2004012733A2/en not_active Ceased
- 2003-07-31 BR BR0312929-2A patent/BR0312929A/pt not_active IP Right Cessation
- 2003-07-31 MX MXPA05001235A patent/MXPA05001235A/es unknown
- 2003-07-31 DE DE60316297T patent/DE60316297T2/de not_active Expired - Lifetime
- 2003-07-31 KR KR1020057001801A patent/KR20050026091A/ko not_active Withdrawn
- 2003-07-31 IL IL16604003A patent/IL166040A0/xx unknown
- 2003-07-31 EP EP03766118A patent/EP1526851B1/de not_active Expired - Lifetime
- 2003-07-31 PL PL03375318A patent/PL375318A1/xx not_active Application Discontinuation
- 2003-07-31 CN CNA038183730A patent/CN1671378A/zh active Pending
- 2003-07-31 AT AT03766118T patent/ATE372770T1/de not_active IP Right Cessation
- 2003-07-31 NZ NZ537809A patent/NZ537809A/en unknown
- 2003-07-31 AU AU2003260280A patent/AU2003260280A1/en not_active Abandoned
- 2003-07-31 JP JP2005505653A patent/JP2005537336A/ja not_active Withdrawn
- 2003-07-31 CA CA002493253A patent/CA2493253A1/en not_active Abandoned
-
2005
- 2005-02-28 NO NO20051074A patent/NO20051074L/no unknown
- 2005-03-01 IS IS7723A patent/IS7723A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050026091A (ko) | 2005-03-14 |
| EP1526851A2 (de) | 2005-05-04 |
| EP1526851B1 (de) | 2007-09-12 |
| JP2005537336A (ja) | 2005-12-08 |
| IL166040A0 (en) | 2006-01-15 |
| WO2004012733A3 (en) | 2004-03-18 |
| NO20051074L (no) | 2005-04-29 |
| MXPA05001235A (es) | 2005-06-08 |
| US20060058395A1 (en) | 2006-03-16 |
| IS7723A (is) | 2005-03-01 |
| ATE372770T1 (de) | 2007-09-15 |
| AU2003260280A1 (en) | 2004-02-23 |
| NZ537809A (en) | 2007-05-31 |
| CN1671378A (zh) | 2005-09-21 |
| DE60316297T2 (de) | 2008-06-19 |
| WO2004012733A2 (en) | 2004-02-12 |
| BR0312929A (pt) | 2005-07-12 |
| WO2004012733A9 (en) | 2005-03-10 |
| CA2493253A1 (en) | 2004-02-12 |
| PL375318A1 (en) | 2005-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA83194C2 (ru) | Производные пиримидина и их применение как модуляторов св2 | |
| GB0222495D0 (en) | Compounds | |
| DE60316297D1 (de) | Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antworten | |
| PT1543011E (pt) | Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina | |
| ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
| JO2534B1 (en) | Pyrimidines carrying alternatives of sulfoximine as CDK and / or VEGF inhibitors and their production and use as pharmaceutical agents | |
| BR0318383A (pt) | derivados de pirazoloisoquinolina como inibidores de cinase | |
| ATE381935T1 (de) | Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen | |
| DE60329123D1 (de) | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten | |
| DE60228103D1 (de) | Chemische verbindungen | |
| GEP20084420B (en) | Use of imidazole compounds for the treatment of neurodegenerative disorders | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| BR0312446A (pt) | 2-heteroaril carboxamidas | |
| DE60308699D1 (en) | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren | |
| DE602004018658D1 (de) | 8-(1-piperazinyl)-chinolinderivate und deren verwendung bei der behandlung von zns-erkrankungen | |
| ATE407119T1 (de) | Pyridinderivate und deren verwendung als modulatoren des cb2-rezeptors | |
| ES2333026T3 (es) | Derivados de ciclohexil-1,4-diamina sustituidos. | |
| CR8009A (es) | Compuestos benzo[1,2,5] tiadiazoles | |
| WO2021099966A3 (en) | Novel benzothiophene derivatives and use thereof for stimulating mitochondrial turnover | |
| EP1597234A4 (de) | Neue verbindungen | |
| DE60228295D1 (de) | Chemische verbindungen | |
| ATE482217T1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| ATE359088T1 (de) | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten | |
| ATE360062T1 (de) | Deglykosilierte fragmente der kringle 1-5 region von plasminogen und verwendungsverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |